PHARMAC appeal on treatment for ultra-rare blood disease
New Zealanders rallying PHARMAC for life-saving treatment for ultra-rare blood disease
Eight Kiwis battling an ultra-rare blood disease that claims the lives of one-in-three patients within five years of diagnosis, if untreated, will be appealing to PHARMAC this Thursday, January 24, to save their lives.
A life-saving treatment renowned for its powerful reversal of disease progression, is available under funding arrangements in more than 40 countries world-wide.
Yet New Zealand remains an anomaly – the only country in the advanced OECD not funding the treatment for its citizens.
If these Kiwis don’t get access to this treatment, they will die. It’s simply a matter of time.
Their only hope for survival rests in the hands of NZ government medicines-funding agency, PHARMAC.
Download full media kit THURS, JAN 24 @ www.pnhsanz.org.nz/media
Click for big version.